Butorphanol (+) - sel de tartrate,>=99 %

Code: b9156-100mg D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

κ/µ opioid receptor agonist.

Features and Benefits

This compound was developed by Bristol-Myers Squibb. To brow...


en savoir plus

Votre prix
£219.00 100MG
DEMANDER

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

κ/µ opioid receptor agonist.

Features and Benefits

This compound was developed by Bristol-Myers Squibb. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

assay≥99%
drug controlUSDEA Schedule IV; psychotrope (France); regulated under CDSA - not available from Sigma-Aldrich Canada
formpowder
Gene Informationhuman ... OPRK1(4986), OPRM1(4988)
InChI keyGMTYREVWZXJPLF-BTVKVFNOSA-N
InChI1S/C21H29NO2.C4H6O6/c23-17-7-6-16-12-19-21(24)9-2-1-8-20(21,18(16)13-17)10-11-22(19)14-15-4-3-5-15;5-1(3(7)8)2(6)4(9)10/h6-7,13,15,19,23-24H,1-5,8-12,14H2;1-2,5-6H,(H,7,8)(H,9,10)/t19-,20+,21-;1-,2-/m11/s1
originatorBristol-Myers Squibb
Quality Level200
SMILES stringO[C@H]([C@@H](O)C(O)=O)C(O)=O.Oc1ccc2C[C@H]3N(CC[C@@]4(CCCC[C@@]34O)c2c1)CC5CCC5
storage temp.2-8°C
Cas Number58786-99-5
Ce produit répond aux critères suivants: